Twist Bioscience Corp — Director's Dealing 2021

Feb 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-02-09

Reporting Person: BARTHELEMY NICOLAS (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-09	Common Stock	M	5000	$23.33	Acquired	6898	Direct
2021-02-09	Common Stock	S	5000	$177.6069	Disposed	1898	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-09	Director Stock Option (right to buy)	$23.33	M	5000	Disposed	2029-10-23	Common Stock (5000)	Direct

Footnotes

F1: Represents the weighted average sales price per share. The shares sold at prices ranging from $177.22 to $178.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F2: 1/3rd of the shares subject to the option vested and became exercisable on October 24, 2020 and each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.